If transfer factor is so effective,
then why hasn't the pharmaceutical industry jumped
on it?
I think that is exactly what we are seeing in
many countries, notably China, Czechoslavakia, Germany, Hungary,
Poland, and Japan. In the US, transfer factor has had an
interesting history. The idea of transfer factor flies in
the face of conventional immunology. In the 1950's, antibiotics were
the golden child of medicine, followed in the 60's by
steroids like cortisone for inflammation and the synthetic
steroid hormones like ethinyl estrogen and progestin that
were used to create the birth control pill. After an initial delay,
transfer factor hit its heyday in the 70's and early 80's.
Results, however, were inconsistent as researchers dove in
sometimes with more enthusiasm than skill. The key feature
that was missing in these investigations was a dependable
assay technique for quality control of the product. The
quality control issue was not resolved until the mid 1980's.
Given that transfer factor is not a single entity, the pharmaceutical
companies had fits trying to purify the material without losing
efficacy. This attempted force-fit into the single-entity, single-function
drug dogma was disastrous. The next issue that slowed
transfer factor research is the age-old issue of funding. When AIDS
hit the popular press, politicians shifted funding into AIDs
research, but with focus on finding the cause and then finding a drug that
would cure AIDs. The work of a few, dedicated, but under-funded researchers
and the inability of the mainstream medical-pharmaceutical
industry have combined to again focus attention on transfer factor
as one of the few modalities that is effective against diseases
of viral origin.